MOBERG PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.5 SEK | -2.60% |
|
+2.08% | +67.76% |
| May. 14 | Moberg Pharma AB Elects Jonas Ekblom as Board Member | CI |
| May. 07 | Moberg Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Moberg Pharma AB
7c73ff1178e36b53e9aa7de52f2b3.vBCfp1Dh06yn5NgR2grdo3KJKzb7G7T5ZLpYCPwdYUM.1kmu6AmvjIGV0-5JokC6-THWf3yWQ-WNMv5vZq5qBnbratCQHdinmtay7A~e4caa61873feba1f47c150a50dc85a1d
Upcoming events on Moberg Pharma AB
Past events on Moberg Pharma AB
| 2024-05-29 | Redeye Growth Day |
| 2024-05-15 | Redeye Investor Forum |
| 2024-05-14 08:00 am | Annual General Meeting |
| 2024-05-07 02:00 am | Q1 2024 Earnings Release |
| 2024-05-06 | Q1 2024 Earnings Call |
| 2024-02-13 02:00 am | Q4 2023 Earnings Release |
| 2024-02-12 | Q4 2023 Earnings Call |
| 2023-11-23 05:20 am | Redeye Life Science Day |
| 2023-11-07 02:00 am | Q3 2023 Earnings Release |
| 2023-11-06 | Q3 2023 Earnings Call |
| 2023-11-05 | Bio-Europe Conference |
| 2023-10-10 | European Academy of Dermatology and Venereology Conference |
| 2023-10-09 03:30 am | Extraordinary Shareholders Meeting |
| 2023-08-30 | Redeye Investor Forum |
| 2023-08-10 | Rights Issue: 16 new shares @ 5.75 SEK for 9 existing shares |
| 2023-08-10 | Rights Issue: 16 new shares @ 5.75 SEK for 9 existing shares |
| 2023-08-08 08:00 am | Extraordinary Shareholders Meeting |
| 2023-08-03 02:00 am | Q2 2023 Earnings Release |
| 2023-08-02 | Q2 2023 Earnings Call |
| 2023-05-31 | Redeye Growth Day |
Past dividends on Moberg Pharma AB
| 2021-02-03 | 0 SEK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 15,6 0,00 - | 50,5 | 0,00 | 0,21 21,0 -99.01% | 0,00 0,00 - | 6,00 |
|
EBITDA Million SEK | Released Forecast Spread | -3,00 -20,0 85% | 0,00 | -25,0 | -17,6 -17,0 -3.79% | -25,4 -29,0 12.54% | -36,0 |
|
EBIT Million SEK | Released Forecast Spread | -4,22 -20,0 78.9% | 0,00 | -29,0 | -20,2 -21,0 3.69% | -27,5 -32,0 14.18% | -37,0 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -5,07 -21,0 75.88% | 0,00 | 0,00 | 0,00 0,00 - | -25,4 -31,0 18% | -36,0 |
|
Net income Million SEK | Released Forecast Spread | 559 -21,0 2761.02% | 0,00 | 0,00 | -15,7 0,00 - | -21,1 -25,0 15.63% | -29,0 |
|
EPS SEK | Released Forecast Spread | 314 -12,0 2712.5% | 4,60 | 0,00 | -2,10 0,00 - | -1,33 -1,20 -10.83% | -7,00 |
| Announcement Date | 27/09/19 | 09/02/21 | - | 07/02/23 | 13/02/24 | - |
More events
Past sector events for Moberg Pharma AB
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MOB Stock
- Calendar Moberg Pharma AB
